| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Bozigian Haig P. is a Chief Development Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $25.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2018 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 36,295 | $110.00 | $3,992,450.00 | -11.8% | |
| Nov 7, 2018 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 38,819 | $110.13 | $4,275,299.78 | -6.7% | |
| Mar 5, 2018 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 75,873 | $90.00 | $6,828,570.00 | -21.8% | |
| Feb 5, 2018 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 2,262 | $83.10 | $187,976.53 | -0.8% | |
| Jan 16, 2018 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 1,625 | $79.12 | $128,574.71 | -1.2% | |
| Sep 6, 2017 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 26,250 | $60.00 | $1,575,000.00 | -9.2% | |
| Aug 4, 2017 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 22,500 | $50.00 | $1,125,000.00 | -8.0% | |
| Apr 12, 2017 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 13,065 | $50.42 | $658,773.93 | -4.8% | |
| Feb 6, 2017 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 963 | $43.14 | $41,543.82 | -0.8% | |
| Feb 3, 2017 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 1,375 | $42.57 | $58,533.75 | -1.2% |